[This corrects the article DOI: 10.3389/fmolb.2018.00009.].
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6142832 | PMC |
| http://dx.doi.org/10.3389/fmolb.2018.00084 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Corrigendum: Abnormal respiratory sounds classification using deep CNN through artificial noise addition.
Front Med (Lausanne)
January 2025
Department of Computer and Network Engineering, College of Information Technology, UAE University, Al Ain, United Arab Emirates.
[This corrects the article DOI: 10.3389/fmed.2021.
View Article and Find Full Text PDFCorrigendum to "Identification and treatment of atypical acetabular fractures having an independent acetabular roof fragment: three-column fractures" [Orthop Traumatol Surg Res. 2022;108:103209].
Orthop Traumatol Surg Res
December 2024
Groupe Hospitalier Paris Saint Joseph, 185, rue Raymond Losserand, 75014 Paris, France. Electronic address:
Corrigendum to "Riluzole ameliorates learning and memory deficits in Aβ25-35-induced rat model of Alzheimer's disease and is independent of cholinoceptor activation" [Biomedicine & Pharmacotherapy, Volume 87, March 2017, Pages 135-144].
Biomed Pharmacother
November 2024
Neurophysiology Research Center, Shahed University, Tehran, Iran.
[Corrigendum] Nucleosome‑binding protein HMGN2 exhibits antitumor activity in human SaO2 and U2‑OS osteosarcoma cell lines.
Oncol Rep
December 2024
Department of Orthopedic Surgery, Changzheng Hospital, Second Military Medical University, Shanghai 200003, P.R. China.
Following the publication of the above article, an interested reader drew to the authors' attention that, in Fig. 5A on p. 1305, the same xenograft tumor image had been selected for a pair of the GFP/U2‑OS experiments, where the images from discretely performed experiments were intended to have been shown.
View Article and Find Full Text PDF[Corrigendum] Zoledronic acid sensitizes breast cancer cells to fulvestrant via ERK/HIF‑1 pathway inhibition .
Mol Med Rep
December 2024
Department of Breast Surgery, Key Laboratory of Breast Cancer in Shanghai, Fudan University Shanghai Cancer Center, Shanghai 200032, P.R. China.
Following the publication of the above article, the authors drew to the Editor's attention that they had inadvertently used the same immunohistochemical image to show the experiments depicting the zoledronic acid‑treated MCF‑7/HIF‑1α xenograft (the 'ZOL/MCF‑7/hif' panel) and the fulvestrant‑treated MCF‑7/vector xenograft (the 'FUL/MCF‑7/cdh' panel) in Fig. 3A on p. 5474.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!